Impact of Bevacizumab on Symptom Burden and Neurological Deficits in Patients With Recurrent Glioblastoma
Clinical trial NCT04974983 · COMPLETED
Trial details
- NCT number
- NCT04974983
- Sponsor
- University Hospital Regensburg
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-09-01
- Primary completion
- 2020-06-30
- Enrollment
- 203
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.